1
Clinical Trials associated with GM-XANTHOA Phase IIa Study to Investigate the Efficacy and Safety Profile of GM-XANTHO in Pressure Ulcer Patients
This is a randomized, placebo-controlled, double-blind, 3-arm, single-center, phase IIa, parallel study to assess the efficacy, safety, and tolerability of topically applied 2.5%, 5% GM-XANTHO plus standard of care in patients with stage II or stage III pressure ulcer.
100 Clinical Results associated with GM-XANTHO
100 Translational Medicine associated with GM-XANTHO
100 Patents (Medical) associated with GM-XANTHO
100 Deals associated with GM-XANTHO